Literature DB >> 2989197

The labeling of high affinity sites of antibodies with 99mTc.

C H Paik, L N Phan, J J Hong, M S Sahami, S C Heald, R C Reba, J Steigman, W C Eckelman.   

Abstract

Labeling of F(ab')2 with 99mTc was investigated. The best labeling procedure for F(ab')2 was then applied to IgG and Fab. Stannous ion was used as the reducing agent for 99mTcO-4 and free DTPA was used as a competing reagent to prevent colloid formation and loosely bound 99mTc. The competition reactions revealed two 99mTc binding sites for F(ab')2 and IgG. One is a high capacity, low affinity site. This accounts for 76 and 84% of total IgG and F(ab')2 binding sites. The labeling of these sites can be prevented if the antibody is labeled in the presence of free DTPA. The second site is a low capacity, high affinity site. The labeling of these sites cannot be prevented by free DTPA. Fab, unlike IgG and F(ab')2, does not have an appreciable percentage of high affinity sites. The determination of sulfhydryl groups using Ellman's reagent indicates the production of 5.5, 4.2 and 0.9 sulfhydryl groups when IgG, F(ab')2 and Fab were exposed to 56 micrograms/mL SnCl2 X 2H2O. These sulfhydryl groups may be the source of the high affinity binding. Biodistribution in mice for 99mTc labeled F(ab')2 and F(ab')2-DTPA, both prepared in the presence of excess free DTPA, was similar to that of F(ab')2-DTPA-111In.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989197     DOI: 10.1016/0047-0740(85)90004-x

Source DB:  PubMed          Journal:  Int J Nucl Med Biol        ISSN: 0047-0740


  7 in total

Review 1.  Immunoscintigraphy for cancer detection: "a thousand ills require a thousand cures".

Authors:  S H de Bie; T C Ferreira; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Radioimmunoimaging of colorectal cancer using (99m)Tc labeled monoclonal antibody.

Authors:  Jin-Yue Hu; Jian-Zhi Su; Zhi-Ming Pi; Jian-Gao Zhu; Guo-Hua Zhou; Qu-Bing Sun
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

3.  99mTc-labeled HAb18 McAb Fab fragment for radioimmunoimaging in nude mice bearing human hepatocellular carcinoma.

Authors:  Kai Qiu; Bo-Chen Wang; Zhi-Nan Chen; Pin Fang; Chen-Gang Liu; Wei-Xin Wan; Yan-Fang Liu
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

4.  Human breast tumor imaging using 111In labeled monoclonal antibody: athymic mouse model.

Authors:  B A Khaw; J S Bailes; S L Schneider; J Lancaster; J Powers; H W Strauss; J C Lasher; W L McGuire
Journal:  Eur J Nucl Med       Date:  1988

5.  First evaluation of technetium-99m dimercaptopropionyl albumin as a possible tracer agent for ventriculography in a volunteer.

Authors:  K A Verbeke; W B Vanhecke; L A Mortelmans; A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1994-09

6.  Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodies.

Authors:  C S Gooden; D E Snook; A A Epenetos
Journal:  Cell Biophys       Date:  1993 Jan-Jun

7.  Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging.

Authors:  J Michael Mathis; Shilpa Bhatia; Alok Khandelwal; Imre Kovesdi; Stephen J Lokitz; Yoshi Odaka; Amol M Takalkar; Tracee Terry; David T Curiel
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.